ArticleBioinformation2025
Minimally invasive versus open surgery among colorectal cancer patients.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-Term Functional Outcomes After Prehabilitation in Frail Older Adults Undergoing Colorectal Cancer Surgery: A One-Year Prospective Cohort Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Minimally Invasive Surgery has become an acceptable substitute for Open Surgery in the management of colorectal cancer, with the claimed benefits of reduced morbidity and quicker recovery. Therefore it is of interest to compare the clinical and oncological results of MIS and OS among 200 patients with colorectal cancer over five years. The patients were evaluated for operative time, complications, hospital stay and disease-free survival. MIS has been demonstrated to be linked to markedly reduced stays in hospital (6 vs. 10 days) and decreased complication rates (15% vs. 25%) versus Open Surgery with similar oncologic outcomes: clearance of margins, as well as five-year disease- free survival, p > 0.05. Thus, data support MIS as an effective and safe method within suitably chosen patients with cancer of the colon and rectum, with advantage at recovery duration and complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.